在需要胰岛素的糖尿病患者中,血红蛋白A1,血糖和高密度脂蛋白胆固醇
相关实验视频
Updated: Oct 6, 2026

11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Lancet (London, England)
|September 9, 1978
概括
糖化血红素A1 (HbA1) 水平与糖尿病患者的血糖相关. 然而,HbA1不能可靠地预测这些患者的高密度脂蛋白 (HDL) 胆固醇水平.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 临床化学 临床化学
背景情况:
- 糖尿病管理需要监测血糖控制.
- 糖化血红素A1 (HbA1) 反映了长期的血糖水平.
- 高密度脂蛋白 (HDL) 胆固醇是心血管疾病的一个关键风险因素.
研究的目的:
- 为了研究HbA1和血糖水平之间的相关性.
- 在需要胰岛素的糖尿病患者中检查HbA1,血糖和HDL胆固醇之间的关系.
- 评估HbA1作为HDL胆固醇度的预测指标.
主要方法:
- 研究包括40名需要胰岛素的糖尿病患者.
- 测量HbA1和并发的血糖.
- 对前一年的临床血糖平均值进行评估.
- 测量了高密度脂蛋白 (HDL) 胆固醇度.
主要成果:
- 在HbA1和并发血糖之间发现了显著的相关性.
- 在前一年的HbA1和临床平均血糖之间观察到显著的相关性.
- 在HbA1和HDL胆固醇度之间没有发现显著的相关性.
- 在血糖和高密度胆固醇度之间没有发现显著的相关性.
结论:
- 在需要胰岛素的糖尿病患者中,HbA1是最近血糖控制的可靠指标.
- 在这组患者中,HbA1不是HDL胆固醇水平的适当预测指标.
- 评估HDL胆固醇需要直接测量,独立于血糖控制标记物,如HbA1.1.
相关概念视频
Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

